HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Ishii Selected Research

Gemcitabine

1/2022The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113.
2/2021Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.
1/2021Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.
1/2021A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy.
12/2020Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
12/2020nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients.
11/2019Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer.
10/2018Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407).
8/2018New developments in systemic therapy for advanced biliary tract cancer.
5/2018SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Ishii Research Topics

Disease

47Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 03/2003
36Neoplasms (Cancer)
12/2020 - 08/2003
20Hepatocellular Carcinoma (Hepatoma)
07/2019 - 04/2003
15Infections
01/2022 - 04/2007
14Idiopathic Pulmonary Fibrosis
07/2022 - 06/2005
14Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 01/2005
14Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 05/2006
12Pneumonia (Pneumonitis)
12/2021 - 05/2004
8Disease Progression
01/2022 - 02/2007
8Neutropenia
01/2015 - 12/2005
7Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 06/2012
7Neoplasm Metastasis (Metastasis)
11/2019 - 03/2003
6Sarcoidosis (Schaumann Disease)
08/2020 - 11/2008
6Ascites
04/2017 - 03/2003
5Lung Diseases (Lung Disease)
12/2021 - 03/2005
5Fatigue
10/2021 - 03/2003
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 10/2003
5Adenocarcinoma
11/2014 - 10/2005
5Pulmonary Sarcoidosis
01/2011 - 01/2002
4HIV Infections (HIV Infection)
01/2022 - 05/2011
4Liver Diseases (Liver Disease)
01/2021 - 11/2003
4Cognitive Dysfunction
11/2020 - 02/2009
4Inflammation (Inflammations)
11/2019 - 04/2007
4Vomiting
06/2017 - 03/2003
4Asthma (Bronchial Asthma)
01/2017 - 08/2010
4Fever (Fevers)
09/2016 - 09/2006
4Alzheimer Disease (Alzheimer's Disease)
11/2015 - 07/2008
4Anorexia
01/2013 - 03/2003
4Dementia (Dementias)
05/2012 - 02/2009
4Pulmonary Eosinophilia (Eosinophilic Pneumonia)
01/2010 - 10/2005
3Fibrosis (Cirrhosis)
07/2022 - 10/2003
3Virus Diseases (Viral Diseases)
01/2022 - 12/2014
3Respiratory Tract Diseases (Respiratory Tract Disease)
10/2021 - 09/2004
3Communicable Diseases (Infectious Diseases)
01/2021 - 01/2015
3Dyspnea (Shortness of Breath)
01/2021 - 10/2005
3Human Influenza (Influenza)
01/2021 - 09/2010
3Bronchiectasis
09/2019 - 06/2007
3Rheumatoid Arthritis
01/2019 - 01/2010
3Hypertension (High Blood Pressure)
01/2019 - 04/2014
3Exanthema (Rash)
06/2017 - 01/2008
3Thrombocytopenia (Thrombopenia)
06/2017 - 08/2010
3Granuloma
09/2016 - 01/2002
3Respiratory Insufficiency (Respiratory Failure)
09/2016 - 12/2010
3Trichosporonosis
01/2015 - 01/2007
3Gallbladder Neoplasms (Gallbladder Cancer)
06/2014 - 01/2004
3Eosinophilia
10/2012 - 10/2005
3Nausea
08/2010 - 03/2003
2Body Weight (Weight, Body)
07/2022 - 01/2021
2COVID-19
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

41GemcitabineFDA Link
01/2022 - 01/2005
19Pharmaceutical PreparationsIBA
01/2021 - 10/2005
11Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2005
10Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2005
9VaccinesIBA
01/2022 - 11/2011
9Fluorouracil (Carac)FDA LinkGeneric
10/2018 - 03/2003
7Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 01/2007
7Adrenal Cortex Hormones (Corticosteroids)IBA
09/2016 - 11/2006
6EnzymesIBA
06/2022 - 04/2005
6Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2003
6Irinotecan (Camptosar)FDA LinkGeneric
10/2018 - 03/2007
6AntigensIBA
01/2016 - 01/2004
5PlatinumIBA
01/2021 - 01/2007
5MacrolidesIBA
01/2021 - 09/2004
5Peptides (Polypeptides)IBA
01/2017 - 11/2006
5TegafurIBA
03/2011 - 08/2005
4AntibodiesIBA
01/2022 - 08/2006
4EpitopesIBA
01/2022 - 11/2011
4Clarithromycin (Biaxin)FDA LinkGeneric
01/2021 - 01/2010
4Sorafenib (BAY 43-9006)FDA Link
08/2018 - 01/2008
4SteroidsIBA
01/2018 - 01/2007
4S 1 (combination)IBA
01/2018 - 12/2010
4Donepezil (Aricept)FDA LinkGeneric
11/2015 - 07/2008
4C-Reactive ProteinIBA
01/2015 - 02/2007
4Prednisolone (Predate)FDA LinkGeneric
01/2012 - 10/2005
4UracilIBA
03/2011 - 08/2005
4CollagenIBA
04/2007 - 07/2002
3Neutralizing AntibodiesIBA
01/2021 - 01/2021
3CytokinesIBA
01/2021 - 03/2005
3Immunoglobulins (Immunoglobulin)IBA
01/2021 - 01/2018
3Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2018 - 01/2018
3folfirinoxIBA
10/2018 - 11/2014
3miriplatinIBA
02/2018 - 05/2012
3Interferon-gamma (Interferon, gamma)IBA
09/2016 - 09/2005
3ORALIT (ORS)IBA
07/2016 - 01/2014
3AIDS VaccinesIBA
11/2015 - 05/2011
3InterferonsIBA
01/2012 - 01/2008
2nintedanibIBA
07/2022 - 01/2021
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2021 - 01/2020

Therapy/Procedure

42Drug Therapy (Chemotherapy)
09/2022 - 03/2003
32Therapeutics
12/2020 - 01/2005
11Radiotherapy
01/2021 - 03/2003
9Chemoradiotherapy
02/2021 - 03/2003
8Combination Drug Therapy (Combination Chemotherapy)
02/2022 - 01/2005
4Immunotherapy
11/2019 - 01/2008
4Aftercare (After-Treatment)
04/2015 - 10/2005
3Palliative Care (Palliative Therapy)
09/2022 - 03/2006
3Induction Chemotherapy
02/2021 - 08/2010
3Traction
09/2019 - 06/2007
3Hepatectomy
03/2008 - 11/2006
2Stents
02/2022 - 07/2013